Summary: Forty-six children with the nephrotic
tion of alum-containing vaccines serves to emphasize the need for deep injection, preferably by the intramuscular route for these vaccines (Sauer and Tucker, 1954 ; Burland et al., 1968) . Few would disagree with the advisability of discontinuing pertussis vaccination in children who have suffered a severe generalized reaction to a previous dose of the vaccine. In the case of plain vaccine the wisdom of this may have been justified by the finding of a high incidence of generalized reactions to a second dose of antigens in children who reacted to the first. However, with the adsorbed vaccines generalized reactions were mild and infrequent, and recurrent reactions were not common in those infants who had reacted to a first dose of vaccine. The use of such a vaccine could result in fewer children losing the benefits of a full course of pertussis immunization.
Vaccination in almost all the children in this survey caused the appearance of specific agglutinins ; in this respect vaccines B and C were superior to A. There was considerable individual variation in amounts of specific agglutinins and of bactericidal antibody produced.
Conclusions
The value of the mouse weight gain test as an indicator of reaction-provoking tendencies in children is again shown, and it is suggested that it should continue to be applied to all vaccines containing pertussis antigen. The addition of aluminium hydroxide as adjuvant to diphtheria, tetanus, and pertussis combined 'vaccine served to increase antigen potency and significantly reduce the incidence of generalized reactions in children. A reduction by half in the number of pertussis organisms in the adsorbed combined vaccine did not further reduce reactions and therefore served no useful purpose.
Vaccines containing aluminium hydroxide are in widespread use for immunization against diphtheria and tetanus, and it is suggested that protection in infancy can best be obtained by using an adsorbed diphtheria, tetanus, pertussis vaccine. syndrome whose renal biopsy specimens showed minimal changes and whose response to corticosteroid therapy was unsatisfactory were treated with cyclophosphamide. Three patients were completely steroidresistant from the outset and the remainder were steroiddependent. In several patients steroids controlled the condition less effectively with time. Most patients showed signs of steroid toxicity, and growth retardation was striking.
A moderate leucopenia was induced with cyclophosphamide, and treatment was maintained for three to four months in the majority of cases. Thirty-eight children (83%) have remained in complete remission off all treatment for periods of 3 to 23 months, 33 It is nearly 20 years since cytotoxic drugs were first used in the treatment of the nephrotic syndrome (Chasis et al., 1949 (Chasis et al., , 1950 but they were soon to be replaced by corticosteroids. Recent *The content of this paper was presented in summary at the Clinical follow-up studies, however, have emphasized the limitations of corticosteroid therapy in children. In a five-year follow-up of nephrotic children treated with prednisolone, Arneil and Lam (1966) found that 69% had been well with no proteinuria for at least three years but that 22 % still had active disease and 9 % were dead. Likewise Cornfeld and Schwartz (1966) .
While improvement of renal function followed the use of either drug, we were impressed by the speed with which leucopenia could be reversed on withdrawal of cyclophosphamide, compared with the prolonged and occasionally severe marrow depression induced by azathioprine (White, 1967) . In this paper we report the results of cyclophosphamide treatment in 46 children with the nephrotic syndrome whose renal biopsy specimens showed " minimal changes " and in whom the results of corticosteroid therapy were considered unsatisfactory.
Material and Methods
Initially we regarded active disease of many years' duration and steroid resistance as the two main indications for cyclophosphamide therapy. However, as we gained experience with this treatment and became increasingly aware of the satisfactory results obtained we began to treat children whose disease was ,of shorter duration but who relapsed frequently or remained in remission only at the price of steroid toxicity. The majority of patients were referred by other paediatricians and there was understandably some variation in their management. We have arbitrarily defined a relapse as a recurrence or an increase of proteinuria which, in the opinion of the paediatrician, necessitated a substantial increase in the dose of steroids. This gives only an approximation of the true frequency of relapse as the parents of some patients had themselves increased the dose of steroids at home whenever proteinuria recurred.
Forty-six patients with a minimum follow-up of three months -from the last day of cyclophosphamide therapy are included in this report. Clinical data before starting treatment are given in Table I . There were 33 boys and 13 girls. The age of onset of illness ranged from 11 months to 15 years (mean 5 years). The age when cyclophosphamide therapy was started ranged from 21 to 17 years (mean 10 years) and the duration of disease from 4 months to 13 years (mean 5 years). All patients had been treated with oral steroids but in addition nine received corticotrophin. Seven of these were given azathioprine and a further child was given mercaptopurine, with benefit in only one, who, however, relapsed subsequently. Prednisone and prednisolone were the corticosteroids used most frequently, but cortisone, triamcinolone, dexamethasone, and betamethasone were occasionally used.
Thirty-five children were in relapse at the time that treatment with cyclophoosphamide was started; 28 were on maintenance steroid therapy and seven were off treatment altogether. The remaining 11 patients were in remission but receiving steroids when cyclophosphamide therapy was initiated. Only nine .childrer had not received corticosteroids continuously during the previous year, and they had had remissions of four to 16 weeks' duration. Seventeen of the children had had more than two relapses per year, 15 had had one or two relapses per year, and 11 had had less than one relapse per year (Table I) . Three children showed early resistance to corticosteroids, and seven showed late resistance-that is, they failed to respond to a dose of corticosteroids which had previously induced a remission. The majority of children showed evidence of serious steroid toxicity, and the effect of steroids on growth was striking (Table I) . Only three were above the 50th percentile for height, while 17 were below the 3rd percentile. Percutaneous renal biopsy was performed in all the children, and examination of the specimens by light microscopy showed either normal glomeruli or mild mesangial hypercellularity in all except two children. We have classified these as " minimal changes." In the two exceptions there were minimal changes with focal glomerular obsolescence. The selectivity of the proteinuria was measured in 36 patients by the methods of either Joachim et al. (1964) or Cameron and Blandford (1966) . Thirty-one children had a highly selective proteinuria and five showed slightly reduced selectivity. Serum f,1c-globulin levels were estimated in 33 patients by a simple radial diffusion method (Ogg et al., 1968) and were found to be normal.
Treatment
The basic scheme of treatment has been outlined already (White, 1967 Fig. 1, and The results of treatment were unsatisfactory in the remaining six patients (Table III) . In four children proteinuria persisted. Case 4 was a familial nephrotic with an onset in infancy, whose condition proved resistant to corticosteroids, indomethacin, and azathioprine as well as 10 weeks' treatment with cyclophosphamide. Case 14 did not lose his proteinuria completely, but it decreased from 25 to 1 g. daily. Case 27 received only two short courses of cyclophosphamide, as treatment had to be interrupted owing to ulcerative stomatitis; he developed only transient leucopenia. Case 38 continued to have moderate proteinuria during his six months' treatment with cyclophosphamide, which was combined with prednisolone. The former drug was therefore discontinued while prednisolone was continued in a dose of 10 mg./day. Since Nephrotic Syndrome in Childhood -Moncrieff et al.
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MEDICAL JOURNAL 669 the preparation of Fig. 1 , however, his proteinuria has disappeared and prednisolone is being withdrawn gradually. From Table III it can be seen that there is no relation between cyclophosphamide failure and the duration of previous disease. Despite the fact that five of the patients had highly selective proteinuria (it was not measured in the sixth), three of them showed early steroid resistance and one late resistance. Only two of these children received three months' or more continuous cyclophosphamide therapy.
Complications of Cyclophosphamide Therapy
We deliberately aimed to induce a moderate leucopenia (total W.B.C. less than 4,000/cu. mm.) and frequently observed a reduction of lymphocytes to less than 1,000/cu. mm. This was not regarded as a complication, and in no instance was it accompanied by anaemia or thrombocytopenia. The commonest side-effect was alopecia, which affected 36 children (Table IV) . However, hair growth invariably recurred, usually after, but sometimes before, completion of treatment. Mild anorexia and nausea were experienced by several children, especially at the beginning of treatment, but were reduced to a minimum by giving cyclophosphamide at bedtime, when antiemetics could also be taken without inconvenience from drowsiness. Severe anorexia and vomiting necessitated interruption of treatment in only two patients. Three children receiving prochlorperazine as an antiemetic developed dystonia, which has previously been 'described in association with this drug (Cottom and Newman, 1966) . Three children experienced transient chemical cystitis during treatment and two developed jaundice, which appeared to be due to infective hepatitis. One child developed aphthous stomatitis, which led to discontinuation of treatment, though at the time he was not leucopenic. Cameron, 1968) , the incidence of severe proliferative glomerulonephritis is less than 10 %, the remainder showing either " minimal changes" or mild proliferative glomerulonephritis (White, 1967; Cameron, 1968 We have not attempted an evaluation of other cytotoxic drugs in nephrotic children, apart from patients with severe proliferative glomerulonephritis . Adams et al. (1967) obtained satisfactory results in two adult nephrotic patients with minimal glomerular abnormalities, using a combination of azathioprine and prednisone, but Sharpstone et al. (1969) had no success with the same treatment. Seven children in the present series received azathioprine and none showed any response to treatment in doses of 2-4 mg./kg./day. This drug is currently being assessed in a multicentre international trial. Chlorambucil has also been found effective when given alone to steroid-dependent nephrotic children, and, in combination with mercaptopurine or azathioprine, to those with steroidresistant disease (Bariety et al., 1966 ; Largue et al., 1967) .
The mode of action of cyclophosphamide is uncertain. It is highly effective in the treatment of autoimmune glomerulonephritis in NZB x NZW FI hybrid mice (Russell et at., 1966; Russell and Hicks, 1968) . This effect was attributed to the lympholytic action of cyclophosphamide, and it is of interest that many of our patients developed a striking degree of lymphopenia during treatment. However, evidence of an immunological disturbance is lacking in nephrotic children whose renal biopsy specimens show " minimal changes " (Drummond et al., 1966) . Cytotoxic drugs based on the purine molecule have also been shown to have an anti-inflammatory action (Page et al., 1962) . It is not certain, therefore, whether or not it is necessary to produce a leucopenia, and it is possible that a longer course of treatment with lower dosage might be equally effective.
Minor side-effects are common with cyclophosphamide but do not present insuperable problems. Young children do not mind the alopecia, which generally affects them more severely than adolescents in the dosage we have used. In cases where embarrassment and interference with schooling are anticipated, a wig can be prescribed. New hair often grows curly and may contain blonde streaks initially. One of the two children in whom anorexia and vomiting necessitated interruption of treatment had somewhat exaggerated symptoms during his initial inpatient treatment and it was decided to stop cyclophosphamide after only seven weeks, by which time he was in complete remission. However, he relapsed five weeks later, and after failing to respond to azathioprine and relapsing three more times during the ensuing year he himself requested a further course of treatment. On this occasion he was treated as an outpatient for 14 weeks, with only minimal nausea controlled by cyclizine hydrochloride, and has since been in remission for seven months.
Haemorrhagic cystitis is an infrequent complication, and appears to be due to a direct chemical action of cyclophosphamide metabolites, which are excreted by the kidney (Rubin and Rubin, 1966) . It is managed by encouraging a copious fluid intake and frequent voiding of urine. Two children developed jaundice, presumed to be due to infective hepatitis, which has previously been reported by Fernbach et al. (1962) in one out of 44 children treated with cyclophosphamide for leukaemia. These may be chance occurrences, though the possibility of impaired immune responses to viruses must be considered, while focal hepatic necrosis has also been reported in mice receiving the drug in huge doses of 5 mg./10 g. body weight, which proved 80% lethal (Fox, 1964) . Etteldorf et al. (1967) reported a death associated with severe varicella infection, but the patient, like our two who developed hepatitis, was also receiving corticosteroids and showed adrenal atrophy at necropsy.
Little is known about the teratogenic hazards of cyclophosphamide, or about its long-term effect on the gonads. Marazzini and Macchi (1966) recorded the birth of normal babies after two pregnancies during which the drug was given for Hodgkin's disease. Greenberg and Tanaka (1964) , however, reported the case of a baby born prematurely with absence of both big toes, after a pregnancy in which cyclophosphamide was given in high dosage during the seventh and eighth weeks.
In our experience cyclophosphamide has been remarkably free from serious toxicity. Indeed, we were more impressed by the adverse effects of prolonged corticosteroid therapy, especially on growth, and our aim-which we successfully achieved in most cases-was to discontinue steroid therapy under cover of cyclophosphamide. This has been followed by obvious growth spurts and lessening of obesity in children whom we have followed up for a long enough time. It has been claimed that the use of corticotrophin lessens the risk of adrenal suppression, and it has recently been advocated for children with growth failure (Friedman and Strang, 1966) . However, this treatment does not produce more lasting remissions than oral corticosteroids and has the definite disadvantage that it can only be given by injection. Patients in the present series who had received substantial doses of corticotrophin exhibited markedly Cushingoid features.
Our findings indicate that cyclophosphamide is an effective alternative treatment for steroid-dependent nephrotic children and for those who develop signs of steroid toxicity. We do not, however, recommend that this drug should be used as the primary treatment of the nephrotic syndrome, since it may be expected that about 40 % of affected children will respond satisfactorily to prednisone (Arneil and Lam, 1966) without developing signs of toxicity. The difficulty is to judge at an early stage of the illness which patient will ultimately prove steroid-dependent, and this problem requires further study. In the meantime, cyclophosphamide should be reserved for children fulfilling the criteria which we have defined.
We wish to thank the many paediatricians who have referred patients for invesigation and treatment.
ADDENDUM: Since the preparation of this report the condition of two patients has changed. Case 7 (Fig. 1) 
Introduction
Corticosteroid applications have been so successful in the control of inflammatory reactions of the skin that they are now widely used as a panacea for all dermatoses, but only rarely do undesirable effects occur. Last year I drew attention to an unusual adverse effect of the more potent steroid creams, when used in the treatment of rosacea (Sneddon, 1968) . It appeared that prolonged use did suppress pustule formation but increased the telangiectatic appearance of the skin. If the local applications were stopped the pustules recurred rapidly, often accompanied by oedema of the face. Many patients resumed treatment to suppress this undesirable effect and thus became virtually dependent, being frightened to stop using the preparations. The appearance of rosacea treated with Betnovate (betamethasone 17-valerate) and Synalar (fluocinolone acetonide) has become a familiar sight, and it is the object of this paper to describe the clinical features and response to treatment of 14 patients seen in the past year.
Case 1
A 46-year-old housewife complained of a burning and redness of the face of three years' duration. The eruption, which was pustular at the onset, was rapidly controlled by betamethasone ointment that she had applied twice daily for the whole three years. In recent months the skin had become tender, and bleeding followed brisk rubbing with a towel. Examination in January 1968 showed a diffuse erythema and telangiectasia over the whole face right up to the hair margin. It extended far more peripherally than rosacea usually does. The facial skin appeared thinned, atrophic, * Physician, Rupert Hallam Department of Dermatology, Royal Infirmary, Sheffield.
C and felt somewhat velvety; a number of small subcutaneous haemorrhages similar to senile purpura were present on the forehead and cheeks. Tetracycline 250 mg. twice daily was prescribed and ung. aquosum substituted for the ung. betamethasone. A week later her face became painful and oedematous, but she was encouraged not to resume the betamethasone and to persist with the treatment advised. Tetracycline was continued in a dose of 250 mg. twice daily for two months and once daily for a further three months, at the end of which time the facial skin appeared normal.
Case 2 A housewife aged 40 had treated a facial rash for six years with ung. fluocinolone applied daily. She had tried to stop using it, but the rash, consisting of pustules, recurred within a few days and she felt compelled to use the application again. When first seen in 1968 she showed skin-coloured papules over the forehead, cheeks, and chin, characteristically the abortive papulo-pustules of rosacea, and extensive telangiectasia over the whole forehead, cheeks, and chin. There was a fine downy growth of hair, particularly on the cheeks. The skin appeared thinned, and a number of subcutaneous haemorrhages were present. The eruption was confined to the face and ceased below the angle of the jaw (Special Plate, Figs. 1 and 2) . A biopsy specimen taken from the forehead showed normal epidermis. In the dermis sebaceous glands were prominent and surrounded by inflammatory cells, and, in addition, the dermal collagen showed basophilic degeneration with heavy positivity on elastic staining. Dermal vessels were prominent and dilated. The appearances were those of acne rosacea with dermal atrophy.
She was treated with tetracycline 250 mg. twice daily for one month and then once daily for a further three months, by which time her face appeared normal (Special Plate, Figs. 3 and 4) . During the first two weeks of treatment she complained bitterly that her face had become more painful and swollen. Hydrocortisone ointment was prescribed as a substitute for the fluocinolone, as experience had shown that this did not perpetuate the atrophy.
Case 3
A 34-year-old married bus conductress had controlled a facial eruption with betamethasone ointment for five years. The eruption was described as erythematous with recurrent pustulation. As her face had become more and more telangiectatic she was referred to the dermatological department, where she was seen in March 1968 and advised to stop using the betamethasone ointment. She was admitted to hospital seven days later because the whole of her face and neck had become red, swollen, and covered with pustules, 2 to
